DROSPIRENONE AND ETHINYL ESTRADIOL

Lupin Pharmaceuticals, Inc.🇺🇸 United States

FDA Page

Effective Date: Dec 28, 2023
Approval ID: a8955f3b-afc9-4ef0-8946-9c97ab5b2e05
Products: 1 registered
Version: 5

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS safely and effectively. See full prescribing information for DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS.DROSPIRENONE and ETHINYL ESTRADIOL Tablets, 3 mg/0.03 mg, for oral useInitial U.S. Approval: 2001.

Quick Stats

Total Products1

Labelers2

Label Sections40

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.